Please login to the form below
1
Revenue 2017Pfizer
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.
Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
Acuitas’ LNP technology is already used in the Pfizer/BioNTech COVID-19 vaccine, Comirnaty. ... is excited to be working with Pfizer to advance new vaccines and therapeutic products.”.
Pfizer/BioNTech confirm new global collaboration to develop first mRNA-based shingles vaccine
Pfizer/BioNTech have announced the start of a new collaboration to develop a potential first mRNA-based prophylactic shingles vaccine. ... According to the terms of the agreement, Pfizer will pay BioNTech $225m in upfront costs, while BioNTech will pay
Pfizer/BioNTech receives expanded authorisation from the FDA for its COVID-19 booster
As with Pfizer/BioNTech’s initial vaccine, the booster dose will have the same dosage strength of 30-µg. ... Bourla added that Pfizer “continue to believe that broad use of boosters is essential to preserving a high level of protection against this
US prefers mRNA COVID-19 vaccines over J&J
Citing concerns over blood clots, Americans are now advised that should get the Pfizer-BioNTech or Moderna vaccines in preference to Johnson and Johnson vaccine. ... However, the news seems to have caught Pfizer off-guard which said its talks with the EU
Emergency use of Paxlovid allowed in Europe
Paxlovid, however, works intracellularly on the protease of the SARS-CoV-2 virus by inhibiting viral replication,” said Pfizer. ... The EMA also announced that it has started a ‘comprehensive rolling review’ ahead of a possible application for a
[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Almirall and Evotec team up in multi-target dermatology alliance
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
- Part 1 of the Medscape video interview series
- NHS England appoints Chris Hopson as its new chief strategy officer
- Almirall launches Actinic Keratosis Global Day during Skin Cancer Awareness Month
- Pfizer/BioNTech COVID-19 vaccine produces strong immune response in children
- AbbVie submits Parkinson’s disease therapy to FDA
- When is an agency not an agency?
- Jardiance is first diabetes drug to improve CV outcomes
- Roche shares new positive Ocrevus data for MS patients
- EMA reviewing Biogen’s potential Alzheimer’s drug for use in the EU
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- How to plan, execute and refine an excellent congress experience
- GPs will play a pivotal role in integrated care
PMHub
Research Partnership
Research Partnership has joined Ashfield Advisory, the consulting division of healthcare marketing services company, Ashfield. As the market insights specialist...
Latest intelligence
- When is an agency not an agency?
- The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
- Why big pharma needs to be braver
- The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
